Pharma and social media: an uneasy marriage?
This article was originally published in Scrip
Executive Summary
Despite being the fastest growing marketing medium for many industries, social media channels present major legal and regulatory concerns for the pharma sector. Until the US FDA produces some guidance in this area later this year, pharma companies wanting to enter the fray have much to contemplate, explains Tim Worden.